Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer

SIMPLE SUMMARY: Castration-resistant prostate cancer (CRPC) treatments include next-generation anti-androgen therapies (NGATs), taxane therapy, and PARP inhibitors (PARPi). However, resistance often occurs across and within therapeutic classes, which can complicate sequential treatment options. We d...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaaf, Zachary A., Ning, Shu, Leslie, Amy R., Sharifi, Masuda, Han, Xianrui, Armstrong, Cameron, Lou, Wei, Lombard, Alan P., Liu, Chengfei, Gao, Allen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650051/
https://www.ncbi.nlm.nih.gov/pubmed/37958444
http://dx.doi.org/10.3390/cancers15215273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650051/
https://www.ncbi.nlm.nih.gov/pubmed/37958444
http://dx.doi.org/10.3390/cancers15215273

Ejemplares similares